Teper Daniel Gedeon Insider Trades

Insider Trading History

Track insider trading activity for Teper Daniel Gedeon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $185 185,473 shares
Last Trade
Oct 06, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$727k 185,473 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $5.87k 5,865,280 shares
Last Trade
Oct 06, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$727k 185,473 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $5.75k 5,748,405 shares
Last Trade
Aug 04, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.68M 937,500 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $5.68k 5,679,807 shares
Last Trade
Aug 04, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.41M 868,902 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $1.55k 1,546,751 shares
Last Trade
Jun 24, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 300,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $1.25k 1,246,751 shares
Last Trade
Jun 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$706k 180,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.81k 4,810,905 shares
Last Trade
Jan 26, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$165k 42,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.77k 4,768,905 shares
Last Trade
Jan 19, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$173k 44,200 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.72k 4,724,705 shares
Last Trade
Jan 12, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$154k 39,400 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.69k 4,685,305 shares
Last Trade
Jan 05, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$243k 62,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.62k 4,623,305 shares
Last Trade
Dec 07, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$256k 65,400 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.56k 4,557,905 shares
Last Trade
Oct 26, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72.1k 18,400 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.54k 4,539,505 shares
Last Trade
Oct 19, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$72.9k 18,600 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.52k 4,520,905 shares
Last Trade
Oct 12, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$74.5k 19,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.5k 4,501,905 shares
Last Trade
Oct 05, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$160k 40,700 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.46k 4,461,205 shares
Last Trade
Sep 01, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.7k 7,569 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $0 0 shares
Last Trade
Jul 08, 2015 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$47 12 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $4.45k 4,453,636 shares
Last Trade
Jul 08, 2015 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$34.9k 8,905 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $250 250,000 shares
Last Trade
May 06, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$980k 250,000 shares
$3.92
$0.00
Immune Pharmaceuticals
Immune Pharmaceuticals IMNPQ
10% owner, CEO
Holding Value $2.4 2,400 shares
Last Trade
Jun 23, 2014 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.24k 2,400 shares
$2.60
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up